Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice

被引:167
作者
Stewart, Gavin B. [1 ]
Altman, Douglas G. [2 ]
Askie, Lisa M. [3 ]
Duley, Lelia [4 ]
Simmonds, Mark C. [1 ]
Stewart, Lesley A. [1 ]
机构
[1] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England
[2] Univ Oxford, Ctr Stat Med, Oxford, England
[3] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia
[4] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham NG7 2RD, England
关键词
PATIENT DATA METAANALYSIS; RANDOMIZED-TRIALS; META-REGRESSION; LEVEL; MODEL; HETEROGENEITY; TIME;
D O I
10.1371/journal.pone.0046042
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Individual participant data (IPD) meta-analyses that obtain "raw'' data from studies rather than summary data typically adopt a "two-stage'' approach to analysis whereby IPD within trials generate summary measures, which are combined using standard meta-analytical methods. Recently, a range of "one-stage'' approaches which combine all individual participant data in a single meta-analysis have been suggested as providing a more powerful and flexible approach. However, they are more complex to implement and require statistical support. This study uses a dataset to compare "two-stage'' and "one-stage'' models of varying complexity, to ascertain whether results obtained from the approaches differ in a clinically meaningful way. Methods and Findings: We included data from 24 randomised controlled trials, evaluating antiplatelet agents, for the prevention of pre-eclampsia in pregnancy. We performed two-stage and one-stage IPD meta-analyses to estimate overall treatment effect and to explore potential treatment interactions whereby particular types of women and their babies might benefit differentially from receiving antiplatelets. Two-stage and one-stage approaches gave similar results, showing a benefit of using anti-platelets (Relative risk 0.90, 95% CI 0.84 to 0.97). Neither approach suggested that any particular type of women benefited more or less from antiplatelets. There were no material differences in results between different types of one-stage model. Conclusions: For these data, two-stage and one-stage approaches to analysis produce similar results. Although one-stage models offer a flexible environment for exploring model structure and are useful where across study patterns relating to types of participant, intervention and outcome mask similar relationships within trials, the additional insights provided by their usage may not outweigh the costs of statistical support for routine application in syntheses of randomised controlled trials. Researchers considering undertaking an IPD meta-analysis should not necessarily be deterred by a perceived need for sophisticated statistical methods when combining information from large randomised trials.
引用
收藏
页数:8
相关论文
共 36 条
[1]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[2]   Combining heterogenous studies using the random-effects model is a mistake and leads to inconclusive meta-analyses [J].
Al khalaf, Mohamad M. ;
Thalib, Lukman ;
Doi, Suhail A. R. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (02) :119-123
[3]  
[Askie and The Perinatal Antiplatelet Review of International Trials (PARIS) Collaboration Steering Group PARIS Collaboration], 2005, BMC PREGNANCY CHILDB, V5, P7
[4]  
[Askie and The Perinatal Antiplatelet Review of International Trials (PARIS) Collaboration Steering Group PARIS Collaboration], 2005, BMC PREGNANCY CHILDB, V1, P11
[5]   Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data [J].
Askie, Lisa M. ;
Duley, Lelia ;
Henderson-Smart, David J. ;
Stewart, Lesley A. .
LANCET, 2007, 369 (9575) :1791-1798
[6]   Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head [J].
Berlin, JA ;
Santanna, J ;
Schmid, CH ;
Szczech, LA ;
Feldman, HI .
STATISTICS IN MEDICINE, 2002, 21 (03) :371-387
[7]   Individual patient data meta-analysis of time-to-event outcomes: one-stage versus two-stage approaches for estimating the hazard ratio under a random effects model [J].
Bowden, Jack ;
Tierney, Jayne F. ;
Simmonds, Mark ;
Copas, Andrew J. ;
Higgins, Julian P. T. .
RESEARCH SYNTHESIS METHODS, 2011, 2 (03) :150-162
[8]  
Clarke M.J., 2001, Systematic review in health care, mata-analysis in context, V1st, P109
[9]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[10]   SYSTEMATIC REVIEWS - METAANALYSIS AND ITS PROBLEMS [J].
EYSENCK, HJ .
BRITISH MEDICAL JOURNAL, 1994, 309 (6957) :789-792